U.S. Logistics Stock News

NYSE:USAC
NYSE:USACEnergy Services

A Look At USA Compression Partners (USAC) Valuation After Recent Unit Price Pullback

What USA Compression Partners stock’s recent performance suggests USA Compression Partners (USAC) has drawn investor interest after a period where the unit price showed a 1 day decline of about 1%, set against positive returns over the past month and the past 3 months. See our latest analysis for USA Compression Partners. That small 1 day share price pullback sits against a 30 day share price return of 5.65% and a 90 day gain of 10.97%, while the 5 year total shareholder return of 212.85%...
NasdaqGS:LINE
NasdaqGS:LINEIndustrial REITs

Assessing Lineage (NasdaqGS:LINE) Valuation After Q4 Profit Swing And Narrowed Annual Net Loss

Lineage (LINE) is back in focus after reporting fourth quarter and full year 2025 results, which included a swing to a Q4 profit and a sharply smaller annual net loss, catching investors’ attention. See our latest analysis for Lineage. At a share price of US$40.52, Lineage has seen a 5.8% 7 day share price return, a 13.5% 30 day share price return, and a 14.4% year to date share price return. However, its 1 year total shareholder return of a 29.3% decline shows that recent momentum is...
NYSE:Q
NYSE:QSemiconductor

A Look At Qnity Electronics (Q) Valuation After Earnings Beat And New Buyback Plan

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...
NasdaqGS:PFBC
NasdaqGS:PFBCBanks

Assessing Preferred Bank (PFBC) Valuation After Recent Share Price Weakness

Preferred Bank (PFBC) has drawn fresh attention after recent trading left the stock around $87.72. Mixed returns over the past week, month and past 3 months are prompting investors to reassess its current valuation. See our latest analysis for Preferred Bank. The recent 1 day share price decline of 3.36% and year to date share price return of negative 8.57% contrast with a 1 year total shareholder return of 3.12%. This suggests shorter term momentum has cooled even as longer term holders have...
NYSE:MSGE
NYSE:MSGEEntertainment

Does Oracle-Linked Data Breach Shift the Bull Case for Madison Square Garden Entertainment (MSGE)?

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Astec Industries (ASTE) Is Up 7.2% After Record 2025 Sales and Upbeat 2026 Outlook - What's Changed

Astec Industries, Inc. has now reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$400.6 million from US$359.0 million and full-year sales reaching US$1.41 billion, while net income increased to US$38.8 million for 2025 and the Board maintained a quarterly dividend of US$0.13 per share payable in March 2026. Despite Q4 net income easing year on year, the company delivered record quarterly and annual sales, beat analyst earnings and revenue expectations,...
NYSE:IMAX
NYSE:IMAXEntertainment

Why IMAX (IMAX) Is Up 16.4% After Record 2025 Results And New Apple TV F1 Deal

IMAX Corporation recently reported fourth-quarter 2025 revenue of US$125.21 million and full-year 2025 revenue of US$410.21 million, with annual net income rising to US$34.88 million even as quarterly net income softened. The company paired these record box office and revenue results with ongoing global network expansion and deeper local-language and live-event content partnerships, including a new collaboration with Apple TV to screen select 2026 Formula One races in IMAX theaters. We’ll...
NYSE:CHE
NYSE:CHEHealthcare

Chemed (CHE) Is Down 13.8% After Weaker 2025 Earnings And Soft 2026 Guidance Has The Bull Case Changed?

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...
NYSE:ALL
NYSE:ALLInsurance

Allstate’s Higher Dividends (ALL) Raise a Question About Its Evolving Capital Allocation Priorities

In February 2026, The Allstate Corporation declared approximately US$29.3 million in cash dividends on its Series H, I and J preferred stock for the January 15 to April 14 period, payable on April 15 to stockholders of record on March 31, alongside board approval of a higher quarterly common dividend of US$1.08 per share. This combination of stronger earnings, improved auto and homeowners loss ratios, and increased common and preferred dividends underlines management’s confidence in the...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

A Look At Tarsus Pharmaceuticals (TARS) Valuation After 2025 Results And New Shelf Registration

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

The Bull Case For Copart (CPRT) Could Change Following Softer Q2 Revenue And Earnings Trends – Learn Why

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Assessing Erie Indemnity (ERIE) Valuation After 2025 Earnings And Planned CEO Transition

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...
NYSE:TRNO
NYSE:TRNOIndustrial REITs

Assessing Terreno Realty (TRNO) Valuation As Recent Gains Put Focus On Mixed Signals

Why Terreno Realty is on investors’ radar today Terreno Realty (TRNO) is drawing fresh attention after recent price moves, with the stock last closing at US$66.06 and showing mixed returns over the past month and past 3 months. See our latest analysis for Terreno Realty. Terreno Realty’s recent move to US$66.06 comes alongside a 7.34% 1 month share price return and an 11.93% year to date share price return. Its 5 year total shareholder return of 36.75% points to steadier long term...
NYSE:NUE
NYSE:NUEMetals and Mining

How Nucor’s New US$4 Billion Buyback And Leadership Shift At NUE Has Changed Its Investment Story

Nucor Corporation’s board recently declared a regular quarterly cash dividend of US$0.56 per share, its 212th consecutive payout, and authorized a new US$4.00 billion share repurchase program after completing the prior US$3.69 billion buyback. The company also reshaped its senior leadership team by appointing John L. “Jack” Sullivan as Chief Financial Officer, Treasurer and Executive Vice President, following Steve Laxton’s earlier move to President and Chief Operating Officer. We’ll now...
NYSE:DX
NYSE:DXMortgage REITs

How Dynex Capital’s New CFO From Capital Markets May Subtly Reshape DX’s Risk‑Return Profile

Dynex Capital, Inc. recently appointed Michael Sartori, formerly Head of Capital Markets and Financial Planning and Analysis, as Chief Financial Officer, succeeding Robert Colligan, who will remain in an advisory role until May 1, 2026, with the company stating the transition is unrelated to financial reporting or control issues. Sartori’s long tenure at Dynex and deep experience in capital markets, derivatives accounting, and financial modeling positions him to influence how the mortgage...
NYSE:BDC
NYSE:BDCElectronic

Assessing Belden (BDC) Valuation After Strong Recent Share Price Momentum

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...
NYSE:MCB
NYSE:MCBBanks

Metropolitan Bank (MCB) Is Down 6.2% After $178.5M Equity Raise To Fund Tech Push

Metropolitan Bank Holding Corp. recently completed a follow-on public offering of 2,100,000 common shares at US$85.00 each, raising about US$178.5 million to bolster capital and fund organic growth, technology investment, and general corporate purposes. The move meaningfully expands the bank’s equity base while supporting its post–Project Phoenix push into technology and AI-driven efficiency, reshaping how it finances future expansion. We’ll now examine how this sizeable equity raise, aimed...
NYSE:ABG
NYSE:ABGSpecialty Retail

Is Asbury’s US$500 Million Buyback And Dealership Sales Reshaping The Investment Case For ABG?

Asbury Automotive Group recently completed the sale of ten dealerships, generating about US$210 million in net proceeds and expanding its authorized share repurchase program to US$500 million, while also exiting a Chrysler Dodge Jeep Ram store that was acquired and rebranded as Indy CDJR by Matt Bowers. Together, these moves highlight Asbury’s ongoing portfolio reshaping and its preference to return capital to shareholders rather than reinvest all proceeds into owned dealership...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

How Investors May Respond To Farmers National Banc (FMNB) Margin Pressures And Rising Credit Risk Concerns

Farmers National Banc recently drew heightened attention as a regional lender with a traditional community banking model centered on Ohio and nearby Midwest markets, where it is contending with margin pressure from higher deposit costs and slower loan repricing. What makes this situation especially important is the combination of rising credit risks in commercial real estate and small business portfolios with questions about how regulatory scrutiny and the interest‑rate backdrop could affect...
NYSE:CNS
NYSE:CNSCapital Markets

Should Cohen & Steers’ Higher Dividend Payout Shape How Investors View CNS’s Capital Priorities?

Cohen & Steers, Inc. recently declared a first-quarter 2026 cash dividend of US$0.67 per share, up from US$0.62 in the prior quarter, payable on March 19, 2026 to shareholders of record as of March 9, 2026. The 8.1% dividend increase highlights management’s willingness to return more cash to shareholders, which can be an important signal about the firm’s current capital position and confidence in its operations. We’ll now examine how this higher common-stock dividend, alongside the firm’s...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

A Look At Newell Brands (NWL) Valuation As Tariff Pressures Meet Quantum Leap AI Progress

Newell Brands (NWL) is trying to balance tariff pressures with internal change, forecasting a US$130 million cash tariff impact in 2026 while advancing its Quantum Leap AI program to rework costs, workflows, and product development. See our latest analysis for Newell Brands. Despite recent tariff headlines and the Quantum Leap AI rollout, Newell Brands’ 30 day share price return of 7.06% and 90 day gain of 23.98% contrast with a 1 year total shareholder return decline of 22.95%. This points...
NYSE:ESRT
NYSE:ESRTOffice REITs

A Look At Empire State Realty Trust’s Valuation After Earnings, New Leases And Buybacks

Why Empire State Realty Trust is back on investors’ radar Empire State Realty Trust (ESRT) has moved back into focus after fourth quarter 2025 results showed higher quarterly revenue and net income year over year, alongside fresh leasing wins with major tenants. For the fourth quarter, ESRT reported sales of US$159.72 million and revenue of US$199.22 million, compared with US$155.13 million and US$197.6 million a year earlier. Net income came in at US$20.73 million versus US$12.22 million,...
NasdaqGM:FLGT
NasdaqGM:FLGTHealthcare

Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress

Fulgent Genetics (FLGT) is back on investors’ radar after its latest update, with 2025 earnings showing US$322.67 million in sales, a wider net loss, and fresh 2026 revenue guidance of about US$350 million. See our latest analysis for Fulgent Genetics. The share price reaction has been sharp, with a 1 day share price return of a 38.09% decline and a year to date share price return of a 40.09% decline, even though the 1 year total shareholder return is roughly flat. This suggests recent...